Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity Licenses Pathway Analysis Software to French Pharma Servier

NEW YORK, June 9 (GenomeWeb News) - French pharmaceutical firm Servier has licensed Ingenuity's Pathway Analysis product, the companies said today.

 

The license was taken by the Institut de Recherches Servier, a company research center based in Croissy-sur-Seine, a suburb of Paris, which plans to integrate the software into its genomics technology platform.

 

Ingenuity's pathway analysis software makes use of a large curated database of modeled relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.